Found: 16
Select item for more details and to access through your institution.
Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2021, v. 171, n. 4, p. 553, doi. 10.1007/s10517-021-05268-3
- By:
- Publication type:
- Article
Multipotent Mesenchymal Stromal Cells in Patients with Chronic Myeloid Leukemia before Discontinuation of Tyrosine Kinase Inhibitors.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2019, v. 167, n. 4, p. 580, doi. 10.1007/s10517-019-04575-0
- By:
- Publication type:
- Article
Multipotent Mesenchymal Stromal Cells in Patients with Chronic Myeloid Leukemia before Discontinuation of Tyrosine Kinase Inhibitors.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2019, v. 166, n. 6, p. 580, doi. 10.1007/s10517-019-04575-0
- By:
- Publication type:
- Article
Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 2, p. 219, doi. 10.1111/bjh.14829
- By:
- Publication type:
- Article
Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients.
- Published in:
- BMC Medical Genomics, 2019, v. 12, n. 2, p. N.PAG, doi. 10.1186/s12920-019-0481-z
- By:
- Publication type:
- Article
Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia.
- Published in:
- BMC Genetics, 2016, v. 17, p. 35, doi. 10.1186/s12863-015-0308-7
- By:
- Publication type:
- Article
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 8, p. 589, doi. 10.1016/j.clml.2023.04.002
- By:
- Publication type:
- Article
Analysis of the Mortality of Russian Patients With Chronic Myeloid Leukemia in the Multicenter EUTOS ELN Population-based Study (EUTOS-PBS).
- Published in:
- 2020
- By:
- Publication type:
- journal article
ENESTop 192-Weeks Results: Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S288, doi. 10.1016/j.clml.2019.07.233
- By:
- Publication type:
- Article
ENESTop 144-Week Update: Long-Term Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S222, doi. 10.1016/j.clml.2018.07.092
- By:
- Publication type:
- Article
Abstract Index.
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 755, doi. 10.1002/ajh.24034
- By:
- Publication type:
- Article
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 732, doi. 10.1002/ajh.23728
- By:
- Publication type:
- Article
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
- Published in:
- Annals of Internal Medicine, 2018, v. 168, n. 7, p. 461, doi. 10.7326/M17-1094
- By:
- Publication type:
- Article
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0182901
- By:
- Publication type:
- Article